Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →🤖 ML Fraud Detection Score: 87%
Machine learning model identifies prescribing patterns consistent with confirmed fraud cases. This is a statistical indicator, not an accusation.
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
15,333
Total Claims
$1.3M
Drug Cost
828
Beneficiaries
$1,622
Cost/Patient
Risk Score Breakdown 25/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
+49%
Opioid rate vs peers
3.3% vs 2.2% avg
+15%
Cost per patient vs peers
$1,622 vs $1,411 avg
+48%
Brand preference vs peers
15.7% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
3.3%
Opioid Rate
510
Opioid Claims
$21K
Opioid Cost
16.3%
Long-Acting Rate
Brand vs Generic
Brand: 2,392 claims · $1.0M
Generic: 12,852 claims · $310K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 200 | $143K |
| Dulaglutide | 101 | $120K |
| Semaglutide | 83 | $82K |
| Empagliflozin | 68 | $63K |
| Sitagliptin Phosphate | 66 | $51K |
| Linaclotide | 49 | $32K |
| Rivaroxaban | 33 | $25K |
| Insulin Aspart | 87 | $23K |
| Mirabegron | 25 | $19K |
| Insulin Glargine,hum.Rec.Anlog | 64 | $17K |
| Atorvastatin Calcium | 697 | $14K |
| Fluticasone/Vilanterol | 29 | $14K |
| Oxycodone Hcl | 54 | $14K |
| Insulin Degludec | 47 | $14K |
| Insulin Glargine,hum.Rec.Anlog | 101 | $13K |
Prescribing Profile
Patient Profile
73
Avg Age
63%
Female
1.53
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About